Meier C, Knispel T, Marquez V E, Siddiqui M A, De Clercq E, Balzarini J
Institute of Organic Chemistry, Julius-Maximilians-University Würzburg, Am Hubland, D-97074 Würzburg, Germany.
J Med Chem. 1999 May 6;42(9):1615-24. doi: 10.1021/jm981097r.
Novel, lipophilic cycloSal triesters 4a-c and 5a-c were synthesized, respectively, from the ara- and ribo-configurated 2'-fluorinated-2', 3'-dideoxyadenosines 2 and 3. The cycloSal phosphotriesters were used as tools to study the effects of the two different sugar pucker conformations induced by two opposite configurations of the fluorine substituent at C2' of the dideoxyribose moiety. F-ara-ddA (2) is known to be an active anti-HIV agent, whereas the ribo-analogue 3 is inactive. Hydrolysis studies with the triester precursors 4a-c and 5a-c showed selective formation of the monophosphates of 2 and 3. The lipophilicity of the triester prodrugs was considerably increased by the cycloSal mask with respect to ddA (1), F-ara-ddA (2), and F-ribo-ddA (3). Phosphotriesters 4 and 5 proved to be completely resistant to ADA and AMPDA deamination. In parallel experiments, ribo-nucleoside 3 showed a 50-fold faster deamination rate relative to the ara-analogue 2. Against HIV in CEM cells, the phosphotriesters 4 proved to be 10-fold more potent than the parent nucleoside 2. Furthermore, the prodrugs 4 were active against MSV-induced transformation of C3H/3T3 fibroblasts, while 2 was inactive. More interestingly, the ribo-configurated phosphotriesters 5, prepared from the inactive F-ribo-ddA (3), showed a level of anti-HIV activity that was even higher than that of F-ara-ddA (2). Our findings clearly prove that the application of the cycloSal-pronucleotide concept to F-ribo-ddA (3) overcomes a metabolic blockade in the formation of the corresponding monophosphate.
分别由阿拉伯糖构型和核糖构型的2'-氟代-2',3'-二脱氧腺苷2和3合成了新型亲脂性环Sal三酯4a - c和5a - c。环Sal磷酸三酯被用作工具,以研究由二脱氧核糖部分C2'位氟取代基的两种相反构型诱导的两种不同糖环构象的影响。已知F-ara-ddA(2)是一种活性抗HIV药物,而核糖类似物3无活性。对三酯前体4a - c和5a - c的水解研究表明,选择性地形成了2和3的单磷酸盐。相对于ddA(1)、F-ara-ddA(2)和F-ribo-ddA(3),环Sal掩蔽基团使三酯前药的亲脂性显著增加。磷酸三酯4和5被证明对ADA和AMPDA脱氨完全抗性。在平行实验中,核糖核苷3的脱氨速率比阿拉伯糖类似物2快50倍。在CEM细胞中抗HIV方面,磷酸三酯4被证明比母体核苷2强10倍。此外,前药4对MSV诱导的C3H/3T3成纤维细胞转化有活性,而2无活性。更有趣的是,由无活性的F-ribo-ddA(3)制备的核糖构型磷酸三酯5表现出比F-ara-ddA(2)更高的抗HIV活性水平。我们的研究结果清楚地证明,将环Sal - 前核苷酸概念应用于F-ribo-ddA(3)克服了相应单磷酸盐形成中的代谢障碍。